Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Hyundai Says Preclinical Test of Novel Oral Drug Successful in COVID-19

Fosun, BioNTech Form $200 Million China JV to Make COVID-19 Vaccine

WHO Approves Sinopharm's COVID-19 Vaccine for Global Use

Sinovac Starts Review Process for Approval of COVID-19 Vaccine in Europe

RNAImmune Raises $10 Million for mRNA Products and COVID-19 Vaccine

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021